SonoVue® vs. Sonazoid™ vs. Optison™: Which Bubble Is Best for Low-Intensity Sonoporation of Pancreatic Ductal Adenocarcinoma? is a research paper published in Pharmaceutics (2022). On theSindex it has a DataRank of 0. It has been cited 36 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Western Norway Regional Health Authority
Grant: 911779, 911182, 912035 and 912146
Norwegian Cancer Society
Grant: 6833652, 182735
The Research Council of Norway
Grant: 250317, 223250, 262652
National Institute of Health
Grant: R01CA199646
The Research Council of Norway
Grant: 251788
Stimuli responsive layered double hydroxide/CARBon nanotube based COATings with multi-level corrosion PROtection
The Research Council of Norway
Grant: 223250
Centre for Cancer Biomarkers (CCBIO)
National Institutes of Health
Grant: 5R01CA199646-05
Optimizing Ultrasound Enhanced Delivery of Therapeutics
The Research Council of Norway
Grant: 262652
Centre for Cancer Cell Reprogramming (CanCell)
The Research Council of Norway
Grant: 250317
Sonoporation-Emhanced Therapy for the treatment of Pancreatic Adenocarcinoma
FWCI
2.22
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals